Vivos Therapeutics reports mixed Q1 results, aims for growth By Investing.com
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million...
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million...
raisbeckfoto This will be a shorter earnings preview since the stock is a very small position within client accounts, but...
loanDepot, Inc. (NYSE: LDI) has reported a 7% revenue increase in the first quarter of 2024 despite experiencing a cyber...
SÃO PAULO - Embraer S.A. (NYSE: ERJ; B3: EMBR3), a leading aerospace company, announced its financial results for the first...
Pinterest Inc . (NYSE: NYSE:) Adapts to Market Dynamics with New Partnerships and Advertising StrategiesIn the face of a changing...